Contact Us | Sitemap
logo
About ISTA Products Pipeline Careers Investors

Image
ISTA Investor Information


BEPREVE®

(bepotastine besilate
ophthalmic solution) 1.5%
 


Xibrom

(bromfenac ophthalmic
solution)® 0.09%
 


Istalol®

(timolol maleate
ophthalmic solution) 0.5%
 

Investor Highlights

Presentations
Stock Quotes
Quarterly Fact sheet

Products

BEPREVE

Xibrom

Istalol

Vitrase
 

Press Releases

  • ISTA Pharmaceuticals Announces Conference Call and Webcast of Second Quarter 2010 Financial Results
  • ISTA Pharmaceuticals Initiates Clinical Development of Bepotastine Besilate Nasal Spray for the Treatment of Symptoms Associated with Seasonal Allergic Rhinitis
  • ISTA Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences Conference
Top | Contact Us | Products | MSDS | Disclaimer | Sitemap | Educational Grant Requests

© 2010 ISTA pharmaceuticals